Entia Biosciences Inc (ERGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,396 | -963 | -674 | -273 | -2,260 |
| Depreciation Amortization | 93 | 19 | 12 | 6 | 256 |
| Accounts receivable | -1 | 1 | -3 | -2 | 237 |
| Other Working Capital | 482 | 588 | 407 | 146 | 829 |
| Other Operating Activity | 106 | 80 | 56 | 25 | 402 |
| Operating Cash Flow | $-715 | $-275 | $-202 | $-99 | $-537 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -8 |
| Purchase Sale Intangibles | -7 | -7 | -7 | -5 | -13 |
| Other Investing Activity | -7 | -7 | -7 | -5 | -13 |
| Investing Cash Flow | $-7 | $-7 | $-7 | $-5 | $-21 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 829 | 320 | 245 | 95 | 100 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 560 |
| Other Financing Activity | -55 | -60 | -43 | -15 | -178 |
| Financing Cash Flow | $774 | $260 | $202 | $80 | $483 |
| Beginning Cash Position | 24 | 24 | 24 | 24 | 100 |
| End Cash Position | 76 | 2 | 18 | N/A | 24 |
| Net Cash Flow | $52 | $-22 | $-6 | $-24 | $-75 |
| Free Cash Flow | |||||
| Operating Cash Flow | -715 | -275 | -202 | -99 | -537 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -8 |
| Free Cash Flow | -715 | -275 | -202 | -99 | -545 |